Literature DB >> 19697637

Virilizing ovarian hilus (Leydig) cell tumor with concurrent contralateral hilus cell hyperplasia: a rare diagnosis.

M Zafrakas1, I D Venizelos, T D Theodoridis, L Zepiridis, T Agorastos, J N Bontis.   

Abstract

Ovarian hilus or Leydig cell tumor and ovarian hilus cell hyperplasia are rare clinical entities, causing virilization in both pre- and postmenopausal women. Differentiation between these two conditions is not always straightforward; the former is usually unilateral appearing as a single, grossly visible, circumscribed mass of hilus cells, while the latter is usually bilateral, appearing as diffuse microscopic aggregates of hilus cells. We report herein an extremely rare case of ovarian hilus or Leydig cell tumor, presenting concurrently with contralateral ovarian hilus cell hyperplasia in a postmenopausal woman with virilization. To the best of our knowledge, only four such cases have been previously reported in the literature. Ovarian hilus cell tumors and hilus hyperplasia almost always have benign biological behavior, thus making bilateral salpingo-oophorectomy an appropriate and sufficient therapeutic approach.

Entities:  

Mesh:

Year:  2009        PMID: 19697637

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  2 in total

1.  Ovarian leydig cell hyperplasia: an unusual case of virilization in a postmenopausal woman.

Authors:  Jaya M Mehta; Jeffrey L Miller; Anthony J Cannon; Stacey K Mardekian; Lawrence C Kenyon; Serge A Jabbour
Journal:  Case Rep Endocrinol       Date:  2014-06-19

2.  The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.

Authors:  Larisa V Suturina; Eldar M Sharifulin; Maharam A Sharifulin; Ludmila M Lazareva; Irina N Danusevich; Kseniia D Ievleva; Iana G Nadeliaeva
Journal:  Metabolites       Date:  2022-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.